ESR2 and breast cancer: Our previously published work identified c-Abl and EYA2 as the kinase and phosphatase, respectively, that directly and oppositely control ERβ phosphotyrosine status in breast cancer cells.8 It remains to be determined whether these molecules directly regulate the ERβ phosphotyrosine switch in CD8+ T cells.